Skip to main content
TipRanks
Go Ultimate75% OFF

Curatis Holding AG (0QNS) Share Price & Analysis

1 Followers

0QNS Stock Chart & Stats

CHF 17.45CHF 0.00(0.00%)
At close: 4:30 PM GMT
CHF16CHF18CHF20Aug 18Sep 1Sep 14Sep 25Oct 9Oct 30
Day’s Range
CHF 17.45 - CHF 17.45
52-Week Range
CHF 11.55 - CHF 25.00
Previous Close
CHF 17.45
Volume
N/A
Average Volume (3M)
63
Market Cap
CHF 85.03M
Enterprise Value
CHF 111.64M
Total Cash (Recent Filing)
CHF 3.60M
Total Debt (Recent Filing)
CHF 0
Price to Earnings (P/E)
―
Beta
-0.38
Next Earnings
Apr 12, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery

The sharp 2025 revenue rebound indicates improving commercial traction and renewed demand for the company’s pharmaceutical and healthcare activities. If maintained, stronger sales can provide operating leverage, support investment in the portfolio, and improve the foundation for future profitability.

Gross Margin Improvement

Improving gross margin shows that the revenue recovery is accompanied by better economics at the gross-profit level, not just higher sales. Sustained margin expansion would increase the portion of revenue available to cover operating costs and could accelerate the path toward break-even.

Debt-free Balance Sheet

Zero reported debt and a sizeable equity base provide financial flexibility and reduce exposure to interest costs or refinancing pressure. This gives Curatis more capacity to support operations and pursue development while limiting the balance-sheet strain typically associated with leveraged growth.

Bears Say

Persistent Unprofitability

Despite substantial improvement from 2024, the company has not yet reached sustainable profitability across EBIT, EBITDA, or net income. Continued losses can restrict internally funded growth, keep management focused on recovery, and make the improved revenue trend less durable until operating costs are covered.

Worsening Cash Burn

Negative operating and free cash flow show that the business is not yet self-funding, even as reported losses narrow. Worsening cash generation can create continuing funding needs, reduce flexibility for development activities, and weaken the quality of the company’s financial recovery.

Negative Returns On Equity

Negative return on equity indicates that the sizeable capital base is still not generating positive earnings for shareholders. Until returns improve, Curatis may struggle to compound its equity efficiently, while ongoing losses could diminish the strategic benefit of its otherwise strong balance-sheet position.

Curatis Holding AG News

0QNS FAQ

What was Curatis Holding AG’s price range in the past 12 months?
Curatis Holding AG lowest share price was CHF11.55 and its highest was CHF25.00 in the past 12 months.
What is Curatis Holding AG’s market cap?
Curatis Holding AG’s market cap is CHF85.03M.
When is Curatis Holding AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Curatis Holding AG’s earnings last quarter?
Curatis Holding AG released its earnings results on Sep 21, 2026. The company reported -CHF0.078 earnings per share for the quarter.
Is Curatis Holding AG overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Curatis Holding AG pay dividends?
Curatis Holding AG does not currently pay dividends.
What is Curatis Holding AG’s EPS estimate?
Curatis Holding AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Curatis Holding AG have?
Curatis Holding AG has 5,315,944 shares outstanding.
What happened to Curatis Holding AG’s price movement after its last earnings report?
Curatis Holding AG reported an EPS of -CHF0.078 in its last earnings report. Following the earnings report the stock price went up 2.743%.
Which hedge fund is a major shareholder of Curatis Holding AG?
Currently, no hedge funds are holding shares in GB:0QNS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology